Swapnil Malekar – Piper Sandler

Piper Sandler

A Piper Sandler analyst has issued 2 tracked ratings across 2 distinct tickers, with a 0% success rate on the captured sample, and the last rating was made on January 7, 2022.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

4 years ago

2022-01-07 00:00:00+00

Track record

Aggregated

No track record

Bullish: 2
Hold: 0
Bearish: 0

Aggregated

Not available

Recent ratings

Ticker	Date	Rating	Price target	Source
IMRX	2022-01-07	buy	$41.00	Aggregated
IMRXIMMUNEERING CORP - ORDINARY SHARES CLASS A	2022-01-07	unknown	$41.00	Aggregated
NTLA	2022-01-07	buy	$171.00	Aggregated
NTLAINTELLIA THERAPEUTICS INC	2022-01-07	unknown	$171.00	Aggregated

Tickers covered(4)

Ticker	Ratings	Last rating	Sources
IMRX	2	2022-01-07	Aggregated
IMRXIMMUNEERING CORP - ORDINARY SHARES CLASS A	1	2022-01-07	Aggregated
NTLA	2	2022-01-07	Aggregated
NTLAINTELLIA THERAPEUTICS INC	1	2022-01-07	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.